LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Search

Zoetis Inc

Abierto

Sector Salud

193.42 1.22

Resumen

Variación precio

24h

Actual

Mínimo

191.09

Máximo

193.6

Métricas clave

By Trading Economics

Ingresos

25M

624M

Ventas

160M

2.4B

P/B

Media del Sector

33.4

103.001

BPA

1.56

Margen de beneficio

26.441

Empleados

14,100

EBITDA

35M

966M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+14.03 upside

Dividendos

By Dow Jones

Próximas Ganancias

31 oct 2024

Fecha Próximo Dividendo

29 nov 2024

Próxima Fecha de Ex Dividendo

29 oct 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

84B

Apertura anterior

192.2

Cierre anterior

193.42

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

89 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Zoetis Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

6 ago 2024, 11:52 UTC

Ganancias

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

29 abr 2024, 10:57 UTC

Adquisiciones, fusiones, absorciones

Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million

12 abr 2024, 11:47 UTC

Principales Movimientos del Mercado

Zoetis Shares Slip Premarket After WSJ Report on Arthritis Drugs for Pets

13 feb 2024, 12:36 UTC

Ganancias

Zoetis 4Q Net Up 14%, Sees 2024 Growth on Strong Pet, Livestock Demand

6 ago 2024, 11:44 UTC

Ganancias

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6 ago 2024, 11:09 UTC

Ganancias

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6 ago 2024, 11:08 UTC

Ganancias

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6 ago 2024, 11:08 UTC

Ganancias

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6 ago 2024, 11:08 UTC

Ganancias

Zoetis 2Q Adj EPS $1.56 >ZTS

6 ago 2024, 11:00 UTC

Ganancias

Zoetis 2Q Net $624M >ZTS

6 ago 2024, 11:00 UTC

Ganancias

Zoetis 2Q Rev $2.36B >ZTS

6 ago 2024, 11:00 UTC

Ganancias

Zoetis 2Q EPS $1.37 >ZTS

2 may 2024, 17:43 UTC

Ganancias

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 may 2024, 13:06 UTC

Ganancias

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 may 2024, 11:27 UTC

Ganancias

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2 may 2024, 11:00 UTC

Ganancias

Zoetis 1Q Net $599M >ZTS

2 may 2024, 11:00 UTC

Ganancias

Zoetis 1Q EPS $1.31 >ZTS

2 may 2024, 11:00 UTC

Ganancias

Zoetis 1Q Rev $2.19B >ZTS

12 abr 2024, 20:37 UTC

Ganancias

These Stocks Moved the Most Today: JPMorgan Chase, Citigroup, AMD, Intel, Arista Networks, Zoetis, and More -- Barrons.com

13 feb 2024, 12:02 UTC

Ganancias

Zoetis Sees 2024 Adj EPS $5.74-Adj EPS $5.84 >ZTS

13 feb 2024, 12:02 UTC

Ganancias

Zoetis Sees 2024 EPS $5.34-EPS $5.44 >ZTS

13 feb 2024, 12:01 UTC

Ganancias

Zoetis Sees 2024 Net $2.468B-Net $2.513B >ZTS

13 feb 2024, 12:01 UTC

Ganancias

Zoetis Sees 2024 Rev $9.075B-$9.225B >ZTS

13 feb 2024, 12:00 UTC

Ganancias

Zoetis 4Q EPS $1.14 >ZTS

13 feb 2024, 12:00 UTC

Ganancias

Zoetis 4Q Rev $2.21B >ZTS

13 feb 2024, 12:00 UTC

Ganancias

Zoetis 4Q Net $525M >ZTS

2 nov 2023, 11:08 UTC

Ganancias

Zoetis Updates FY23 EPS Guidance Due to Impact of Foreign Exchange Rates >ZTS

2 nov 2023, 11:08 UTC

Ganancias

Zoetis Sees FY23 Adj EPS $5.38-Adj EPS $5.43 >ZTS

2 nov 2023, 11:08 UTC

Ganancias

Zoetis Sees FY23 EPS $5.14-EPS $5.21 >ZTS

2 nov 2023, 11:07 UTC

Ganancias

Zoetis Sees FY23 Net $2.38B-Net $2.415B >ZTS

Comparación entre iguales

Cambio de precio

Zoetis Inc Esperado

Precio Objetivo

By TipRanks

14.03% repunte

Estimación a 12 meses

Media 217.9 USD  14.03%

Máximo 248 USD

Mínimo 200 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zoetis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

10

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

190.44 / 191.73Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

89 / 365 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Zoetis Inc

Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.